Nykode Therapeutics ASA, a clinical-stage biopharmaceutical company based in Oslo, Norway, specializes in developing novel immunotherapies, including vaccines for cancer and infectious diseases. Its leading product candidates are VB10.NEO, a cancer neoantigen vaccine in Phase I/IIa trials for various cancers, and VB10.16, a therapeutic vaccine in Phase II trials...
Rapala stock has been under a lot of sales pressure and are currently trading 0.05 eur below all time low. Inventory are valued at 84.7MEUR while MCAP is 88 MEUR. As the worlds leading fishing equipment manufacturer I find the valuation to be very attractive. Trading volume is low, only 2 analysts cover Rapala and has a price target of 2.7EUR.
EBITDA H1 2024 was...
Lufthansa has been struggling with strike, cancelled flights and increased tax by the German government resulting in weak Q1 results. There is support at around 5,6 EUR and even the slightest positive Q2 report by the end of July should result in a bull run lasting until December/Januar.
